leisure time -WSS

leisure time

author：comprehensive 2025-10-02 13:45:30 - browse：8432

Peter Marks, Director of the Center for Biologics Evaluation and Research at the US Food and Drug Administration (FDA), testifies during a Senate Health, Education, Labor and Pensions Committee hearing to discuss the on-going federal response to Covid-19 on May 11, 2021 at the US Capitol in Washington, DC. — FDA's Peter Marks JIM LO SCALZO/POOL/AFP via Getty Images

WASHINGTON — The Food and Drug Administration needs dozens more reviewers if it wants its so-called Operation Warp Speed for rare disease therapies to take off, the agency’s biologics chief said Monday.

The administration launched the rare disease pilot program, dubbed START and modeled after the record race for a Covid-19 vaccine, this September. Peter Marks, head of the Center for Biologics Evaluation and Research, has spearheaded both initiatives.

“If we were really to expand this significantly, [it] would require us to get dozens of additional staff members,” Marks told listeners during a gene therapy discussion hosted by the Alliance for a Stronger FDA. “One could say ‘Oh my goodness, he’s asking for more headcount again.’ Well, if this really does reduce the time to development by 25 to 50% … it probably won’t take industry too long to do a net present value calculation to say ‘Oh, it’s worth making sure that they have their extra 20 or 30 or 40 reviewers.’”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Texas board proposes rules on abortion law emergency exemption

explore

WSS

This gene therapy has record $4.25 million price. It's saved children.

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

New Medicare drug pricing powers could soon be upended in court

This gene therapy has record $4.25 million price. It's saved children.

Risky weight loss products often used by teens globally, per study

How I ended up pumping milk in a bathroom stall at JPM 2024

entertainment

leisure time

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

State Dept. review finds Biden bears some blame for Afghanistan failures

As JPM 2024 winds down, some health tech firms project optimism

Virginia high school admissions case could be legal follow

Heart disease and mental health: A look at cardiac psychology

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Pregnancy ages women, but effects reverse after delivery

As demand for Covid shots wanes, Moderna seeks its next success

Mirador, a new biotech startup, launches with $400 million

knowledge

Medical devices makers are asking for forgiveness, not permission

Surgeons perform first xenotransplant using CRISPR'd pig kidney

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Biotech investment managers search for lucrative opportunities

Risky weight loss products often used by teens globally, per study

This gene therapy has record $4.25 million price. It's saved children.

Wikipedia

explore

entertainment

Wikipedia